CEIV Pharma certificate for Panalpina’s Brussels station
After a lengthy validation process, Panalpina’s business unit in Brussels had been recognized as CEIV Pharma Certified
“Our capabilities in Brussels and elsewhere in the world are not linked to the infrastructure alone,” says Jaime Aznar, Panalpina’s corporate healthcare quality assurance and regulatory manager. “Our customers can rely on our own trained and very experienced staff on-site. They oversee all operations and immediately intervene if necessary. Our processes are tried and tested.”
Two organizations have now certified Panalpina Brussels, where GDP compliant operations commenced in August 2012, from a healthcare perspective: Belgium’s Federal Agency of Medical and Health Products (FAMHP) and IATA. The CEIV Pharma standard encompasses, or even supersedes, many of the existing pharmaceutical standards.
“Our certifications give our healthcare customers assurance that we can safely handle their valuable and sensitive products, be it human or veterinarian finished products, active pharmaceutical ingredients or medical devices, in a manner that is fully compliant with the highest standards,” says Frank Raeckelboom, Panalpina’s Belgium head of quality, health, safety and environment
Many international pharmaceutical companies have head offices, production sites as well as research and development centers in or close to Brussels. They have told Panalpina that the recent events do not have any impact on the strategic importance of Brussels as a hub for pharmaceutical shipments by air.
Panalpina, present in Belgium since 1968, employs over 170 staff in Brussels, Antwerp and Liège.